why choose us

First received: June 15, 2023

Clinical Trial: Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: Phase 0/I Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors

Brief Summary: The purpose of this study is to test WSD0628 in combination with radiation therapy for recurrent brain tumors.

Read more